COMMUNIQUÉ DE PRESSE publié le 18/10/2023 à 14:30, il y a 2 années 11 mois Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
COMMUNIQUÉ DE PRESSE publié le 12/10/2023 à 14:30, il y a 2 années 11 mois Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
COMMUNIQUÉ DE PRESSE publié le 10/10/2023 à 14:30, il y a 2 années 11 mois Jaguar Animal Health Exhibiting at October 12-14 VCS Annual Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 14:30, il y a 2 années 11 mois Jaguar Health to Present October 3 at LD Micro's Main Event Investor Conference, and on October 5 at the Global Capital Network Investor Conference
COMMUNIQUÉ DE PRESSE publié le 27/09/2023 à 14:30, il y a 3 années Jaguar Health Launches TikTok and Instagram Contest to Raise Awareness About Common Yet Barely Addressed Health Condition: Surprise Diarrhea
COMMUNIQUÉ DE PRESSE publié le 26/09/2023 à 14:30, il y a 3 années Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors
COMMUNIQUÉ DE PRESSE publié le 21/09/2023 à 13:30, il y a 3 années Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating ADHD
COMMUNIQUÉ DE PRESSE publié le 14/09/2023 à 14:30, il y a 3 années Jaguar Health Shares Presentation Replay Link from September 11-13, 2023 H.C. Wainwright Annual Global Investment Conference
COMMUNIQUÉ DE PRESSE publié le 13/09/2023 à 14:30, il y a 3 années Patent Issued in Japan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
COMMUNIQUÉ DE PRESSE publié le 12/09/2023 à 14:30, il y a 3 années Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to National Institute of Allergy and Infectious Diseases for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
Publié le 25/09/2026 à 17:45, il y a 1 jour 21 heures COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Publié le 25/09/2026 à 17:40, il y a 1 jour 21 heures Availability of the 2026 half-year financial report
Publié le 26/09/2026 à 01:00, il y a 1 jour 14 heures Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Publié le 25/09/2026 à 22:15, il y a 1 jour 17 heures Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Publié le 25/09/2026 à 17:30, il y a 1 jour 22 heures Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Publié le 25/09/2026 à 15:00, il y a 2 jours HM Exploration Provides Program Update for the Lewis Pilley's Project
Publié le 26/09/2026 à 15:30, il y a 1 jour QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Publié le 26/09/2026 à 15:30, il y a 1 jour QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Publié le 26/09/2026 à 15:15, il y a 1 jour Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Publié le 26/09/2026 à 07:45, il y a 1 jour 7 heures Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Publié le 26/09/2026 à 00:01, il y a 1 jour 15 heures Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
